For patients with inclusion body myositis (IBM), the anti-NT5C1A antibody is abnormally distributed in the muscle, according to Paik. “It localizes to areas of myonuclear degeneration,” she said.

Patients with idiopathic inflammatory myositis showed active muscle involvement (median creatine kinase level, 4298 U per liter; interquartile range, 766 to 9305), whereas in patients with ...

Recent findings regarding interferon and Janus kinase inhibition may hold clues to improving outcomes in patients with complex myositis, according to a presenter at the Biologic Therapies Summit ...

BARCELONA, Spain — Efgartigimod could have a role to play in the treatment of both myositis and Sjögren disease, according to data from two “proof-of-concept” phase 2 studies reported at ...

Among patients included in the analysis, the average age of IIM onset was 49 years, and median follow-up duration was 5.3 years. Most patients were female (71%), 68% were white, 21% were Black, 3. ...